2D Barcode Scanner for Frozen Samples
Micronic, specialists in traceable sample storage solutions, has announced a further addition to its popular ‘blue-white’ Tracxer Code Reader line.
The Tracxer Code Reader RD235 CRYO offers a high-end solution for scanning whole racks with 2D Data-Matrix or TraXis coded tubes. Featuring a CCD image sensor the new reader provides unmatched high resolution image quality, ensuring the highest accuracy 2D code reading. The Tracxer Code Reader RD235 CRYO features an anti-frost system which minimizes condensation on the scanner plate. This way, tube codes from even frozen samples can be read, thereby improving productivity and preserving the integrity of your samples.
As with all ‘blue-white’ Tracxer Code Readers, the RD235 CRYO is very easy to use. Just a couple of mouse clicks using the highly intuitive Tracxer Code Reader software allows you to scan a complete rack of 2D coded tubes in 7 seconds and a single tube in less than 2 seconds. Using the Tracxer Code Reader RD235 CRYO in conjunction with a Tracxer 1D Rack Barcode Reader BC235 accessory the software allows you to read the 1D rack barcodes and 2D tube codes together.
The Tracxer Code Reader RD235 CRYO provides a complete tube code reading solution for your laboratory whether you use 2D Data Matrix, TraXis or competitive brand 2D-coded tubes to store your samples. The reader is fully compatible with all ANSI/SLAS* standard storage racks, which enables the reading of 12-, 24-, 48-, 96- and even 384-well formats. Due to its compact size, the Micronic Tracxer Code Reader RD235 CRYO is easily integrated into robotic liquid handling and storage systems. It is simple and high performance scanning at its best.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance